Lund Systemic Sclerosis Research Group
1 – 10 of 77
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Treatment with mycophenolate mofetil is associated with improved nailfold vasculature in systemic sclerosis
(
- Contribution to journal › Article
-
Mark
Treatment for Rheumatoid Arthritis Associated With Alterations in the Gastrointestinal Microbiota
(
- Contribution to journal › Article
-
Mark
Increased prevalence of osteopenia and osteoporosis in systemic sclerosis patients, including in men and young women—a case–control study
(
- Contribution to journal › Article
-
Mark
Arrhythmia in patients with systemic sclerosis : incidence, risk factors and impact on mortality in a Swedish register-based study
(
- Contribution to journal › Article
-
Mark
Performance of the EULAR Systemic sclerosis Impact of Disease (ScleroID) questionnaire as a patient-reported outcome measure for patients with diffuse systemic sclerosis
(
- Contribution to journal › Article
- 2023
-
Mark
The validity and reliability of the Swedish version of the Satisfaction with appearance scale for individuals with systemic sclerosis
(
- Contribution to journal › Article
-
Mark
Plasma TRAIL and ANXA1 in diagnosis and prognostication of pulmonary arterial hypertension
(
- Contribution to journal › Article
-
Mark
Systemic sclerosis and primary biliary cholangitis : Longitudinal data to determine the outcomes
(
- Contribution to journal › Article
-
Mark
Elevated fecal levels of the inflammatory biomarker calprotectin in early systemic sclerosis
(
- Contribution to journal › Article
-
Mark
Is classifying SSc-ILD drugs as either immunosuppressive or anti-fibrotic misleading?
(
- Contribution to journal › Letter